2016's Top IPOs
- Twilio, Inc. (TWLO) 172.07%
- Acacia Communications (ACIA) 157.22%
- AveXis (AVXS) 97.05%
- SiteOne Landscape Supply, Inc. (SITE) 77.05%
- Editas Medicine (EDIT) 69.44%
- Reata Pharmaceuticals, Inc. (RETA) 52.82%
- Proteostasis Therapeutics, Inc. (PTI) 36.00%
- BATS Global Markets, Inc. (BATS) 33.00%
- HarborOne Bank (HONE) 30.40%
- MGM Growth Properties LLC (MGP) 28.48%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Argos Therapeutics (ARGS) Files to Offer 19.5M Shares of Common Stock for Holders
- Bear State Financial (BSF) Files $50M Mixed Shelf
- Inventergy Global (INVT) Reports $3M Private Placement
- Ocean Power Technologies (OPTT) Prices 595K Units at $6.75 Each
- ContraFect (CFRX) Prices 14M Common Stock, Warrants Offering for Proceeds of ~$35M
- See More
|7/22/2016||TPI Composites||TPIC||6.25 Mil||$11.00||$13.56||23.27%||J.P. Morgan and Morgan Stanley|
|7/21/2016||Patheon||PTHN||29.762 Mil||$21.00||$25.39||20.90%||J. P. Morgan, Morgan Stanley, Jefferies and UBS|
|7/20/2016||Audentes Therapeutics||BOLD||5 Mil||$15.00||$15.00||0.00%||BofA Merrill Lynch, Cowen and Company and Piper Jaffray|
|7/14/2016||LINE Corp||LN||22 Mil||$32.84||$38.58||17.48%||Morgan Stanley, Nomura, Goldman Sachs, JPMorgan|
|7/8/2016||Monster Digital||MSDI||2.5 Mil||$4.50||$3.42||-24.00%||Axiom Capital, WestPark Capital|
|6/30/2016||HarborOne Bank||HONE||14.454 Mil||$10.00||$13.04||30.40%|
|6/30/2016||Syros Pharmaceuticals||SYRS||4 Mil||$12.50||$11.45||-8.40%||Cowen and Company and Piper Jaffray & Co|
|6/23/2016||Twilio, Inc.||TWLO||10 Mil||$15.00||$40.81||172.07%||Goldman, Sachs & Co., J.P. Morgan, Allen & Company LLC, Pacific Crest Securities, JMP Securities, William Blair, Canaccord Genuity|
|6/22/2016||Selecta Biosciences||SELB||5 Mil||$14.00||$13.77||-1.64%||UBS Investment Bank and Stifel|
|6/10/2016||Atkore International||ATKR||12 Mil||$16.00||$16.70||4.38%||Credit Suisse, Deutsche BankSecurities and J.P. Morgan|
|N/A||Poseidon Containers Holdings Corp.||PCON||N/A||$14-$16||Morgan Stanley, UBS Investment Bank|
|N/A||Digicel Group Limited||DCEL||124.1 Mil||$13-$16||J.P. Morgan, UBS Investment Bank, Citigroup, Barclays, Credit Suisse|
|N/A||GenSight Biologics S.A.||GNST||4.7 Mil||$13-$15||Leerink Partners, Evercore ISI, Canaccord Genuity|
|N/A||VIZIO, Inc.||VZIO||N/A||N/A||BofA Merrill Lynch, Deutsche Bank Securities, Citigroup, BMO Capital Markets, Piper Jaffray, Wells Fargo Securities, Roth Capital Partners|
|N/A||NEP Group||NEPG||13 Mil||$15-$17||Barclays, Morgan Stanley, Jefferies, Macquarie Capital, RBC Capital Markets|
|N/A||Boxlight||BOXL||1.818 Mil||$10-$12||Aegis Capital Corp|
|N/A||ADS Waste Holdings, Inc.||ADSW||N/A||N/A||Deutsche Bank Securities, Credit Suisse, Barclays, BofA Merrill Lynch, Macquarie Capital, Morgan Stanley, UBS Investment Bank, Wells Fargo Securities, First Analysis Securities Corp.|
|N/A||NovoCure Limited||NVCR||N/A||N/A||J.P. Morgan, Deutsche Bank Securities, Evercore ISI, Wells Fargo Securities, JMP Securities, Wedbush PacGrow|
|N/A||PointClickCare Corp.||PCLK||N/A||N/A||J.P. Morgan, Goldman, Sachs & Co., RBC Capital Markets, William Blair, Canaccord Genuity|
|N/A||At Home Group Inc.||HOME||N/A||N/A||BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Morgan Stanley, Evercore ISI, William Blair, Guggenheim Securities, Stifel|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.